Dr. Noura Abul-Husn Receives the 2021 Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award from the ACMG Foundation for Genetic and Genomic Medicine
“That would be our hope, that we could create a drug that targets this and that either prevents the progression of liver disease, which we think would be possible, or could treat some stages of liver disease before it becomes too late.”
“Being able to connect patient’s de-identified medical records with their DNA data is an advantage that few others in this field have. Paired with the RGC’s unique technological and analytical resources, we are able to make meaningful discoveries that may advance the implementation of precision medicine today and the development of new or improved medicines tomorrow,” said Noura Abul-Husn, M.D., Ph.D.
